Haleos Labs Board Meeting on Aug 5 to Approve Unaudited Financial Results

Haleos Labs Ltd has scheduled a Board of Directors meeting for August 5, 2026. The primary agenda is to consider and approve the unaudited financial results for the quarter ended June 30, 2026, on both standalone and consolidated bases. Additionally, the board will review the Board report for the fiscal year 2025-26 and determine the date for the 20th Annual General Meeting. The trading window for designated persons and their immediate relatives will remain closed until August 8, 2026, in compliance with SEBI regulations.